ABA Autism denied as duplicate or overlapping therapy by Aetna?

Aetna's specific coverage criteria for aba autism are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies ABA Therapy as Duplicate Therapy

Applied Behavior Analysis (ABA) therapy for autism spectrum disorder (ASD) is occasionally denied as "duplicate therapy" when Aetna's records show that another behavioral or therapeutic service is already authorized or being billed for the same member during the same period. Common scenarios include concurrent authorization of speech therapy, occupational therapy, or a school-based behavioral program, which a plan reviewer may characterize as serving the same clinical purpose. This denial reason is almost always an oversimplification: ABA addresses a distinct domain of functional skill-building and behavior reduction that is not replicated by other therapies.

## Why This Is Appealable

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), Aetna cannot apply treatment-limitation criteria to mental health/behavioral health services (including ABA for ASD) that are more restrictive than criteria applied to analogous medical or surgical services. A "duplicate therapy" rationale applied to ABA when the same plan would not deny, say, two concurrent physical rehabilitation modalities raises a parity concern. ACA §2719 and ERISA §503 provide internal appeal and external review rights; the external review window is 4 months from final internal denial.

## Documentation to Gather

• Clinical differentiation letter: A letter from the prescribing BCBA (Board-Certified Behavior Analyst) or developmental pediatrician explaining specifically what ABA addresses — targeted behavioral goals, skill domains, treatment protocols — and how these differ from the goals and methods of any concurrent therapy.
• Current treatment plan: The formal ABA treatment plan, including the individualized goals, the number of recommended hours, and the clinical basis for those recommendations.
• Records of other therapies: Documentation of what the other authorized therapies address (e.g., speech articulation, fine motor skills) to demonstrate they are not duplicative.
• Prior authorization records: Any existing Aetna authorizations for concurrent therapies, showing the distinct service codes and goals.
• MHPAEA parity argument: If Aetna would not deny concurrent physical therapy modalities under similar circumstances, note this in your appeal as a potential parity violation.

## Criteria-Mapping Structure

Review Aetna's published clinical policy bulletin for ABA therapy (available on Aetna's provider or member portal). Identify any language about concurrent services. In your appeal, address each basis Aetna cited for the duplicate finding directly, with a column showing the distinct clinical function of ABA relative to the other authorized service.

## Timeline

1. File internal appeal within 180 days of denial. 2. Aetna must decide within 30 days (pre-service) or 60 days (post-service). 3. For urgent ongoing treatment: request expedited review (72 hours). 4. After final internal denial: request external review within 4 months.